Testing effectiveness (Phase 2)Study completedNCT01099527What this trial is testingA Trial of RAD001/Capecitabine in Refractory Gastric CancerWho this might be right forMetastatic Gastric Cancer Samsung Medical Center 59
Early research (Phase 1)Not Yet RecruitingNCT07807345What this trial is testingPhase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or MetastaticWho this might be right forHead & Neck Squamous Cell CarcinomaNon-Small Cell Lung CancerEsophageal Cancer+5 more Sutro Biopharma, Inc. 285
Testing effectiveness (Phase 2)Study completedNCT01275222What this trial is testingEverolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal TumorsWho this might be right forGastrointestinal Stromal Tumors Novartis Pharmaceuticals 117
Early research (Phase 1)Study completedNCT03368196What this trial is testingDS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) ProteinWho this might be right forAdenocarcinoma, GastricNeoplasm, Breast Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company 12
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Very early researchNot Yet RecruitingNCT07166263What this trial is testingSafety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal CancerWho this might be right forGastric Cancer (GC)Colorectal Cancer Base Therapeutics (Shanghai) Co., Ltd. 15
Large-scale testing (Phase 3)UnknownNCT02773524What this trial is testingRegorafenib in Refractory Advanced Gastro-Oesophageal CancerWho this might be right forGastro-Oesophageal Cancer Australasian Gastro-Intestinal Trials Group 250
Testing effectiveness (Phase 2)Study completedNCT00397904What this trial is testingCetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and CisplatinWho this might be right forEsophageal CancerGastric Cancer Memorial Sloan Kettering Cancer Center 16
Early research (Phase 1)Temporarily pausedNCT05400122What this trial is testingNatural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in CancerWho this might be right forColorectal CancerHematologic MalignancyRectum Cancer+15 more David Wald 12
Early research (Phase 1)Ended earlyNCT05013554What this trial is testingDose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid TumorsWho this might be right forNeoplasm MalignantBreast CancerLung Neoplasm Malignant+2 more Sanofi 44
Early research (Phase 1)Study completedNCT03985072What this trial is testingStudy With Andes-1537 in Patients With Specific Types of Advanced Solid TumorWho this might be right forTumor, SolidGall Bladder CancerCervical Cancer+3 more Andes Biotechnologies 67
Very early researchUnknownNCT05886075What this trial is testingA Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid TumorsWho this might be right forLung CancerBronchial CancerNon Small Cell Lung Cancer+9 more Shanghai Yunying Medical Technology 24
Not applicableUnknownNCT04713059What this trial is testingToripalimab Combined With Anlotinib for Patients With Advanced, Relapsed, or Refractory Gastric, or Esophagogastric Junction Cancer (EGJC)Who this might be right forGastric or Gastro-oesophageal Junction CarcinomaAdvanced, Relapsed Gastric or Gastro-oesophageal Junction CarcinomaSecond-line Therapy The Affiliated Hospital of Qingdao University 62
Early research (Phase 1)UnknownNCT04508686What this trial is testingCombination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1)Who this might be right forAdvanced Cervical Cancer Ruijin Hospital 20
Early research (Phase 1)Ended earlyNCT03960060What this trial is testingCCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid TumorsWho this might be right forSolid TumorSoft Tissue SarcomaGastric Cancer+2 more Shanghai PerHum Therapeutics Co., Ltd. 9
Early research (Phase 1)Ended earlyNCT00358397What this trial is testingOne Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard TherapyWho this might be right forTumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Testing effectiveness (Phase 2)UnknownNCT04089657What this trial is testingApatinib Plus Sintilimab in Advanced Gastric Cancer Refractory to at Least Two Previous Chemotherapy RegimensWho this might be right forAdvanced Metastatic Gastric Cancer Fujian Cancer Hospital 40
Large-scale testing (Phase 3)Study completedNCT04879368What this trial is testingRegoNivo vs Standard of Care Chemotherapy in AGOCWho this might be right forGastro-Oesophageal Cancer Australasian Gastro-Intestinal Trials Group 462
Testing effectiveness (Phase 2)Ended earlyNCT03342417What this trial is testingCombination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer PatientsWho this might be right forBreast Cancer FemaleOvarian CancerGastric Cancer ExcellaBio LLC 5
Testing effectiveness (Phase 2)Study completedNCT04338438What this trial is testingEfficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric CancerWho this might be right forGastric Cancer Beijing Friendship Hospital 37